CN1053814C - Medicinal liquid for treating rhinitis and preparation method thereof - Google Patents

Medicinal liquid for treating rhinitis and preparation method thereof Download PDF

Info

Publication number
CN1053814C
CN1053814C CN94101473A CN94101473A CN1053814C CN 1053814 C CN1053814 C CN 1053814C CN 94101473 A CN94101473 A CN 94101473A CN 94101473 A CN94101473 A CN 94101473A CN 1053814 C CN1053814 C CN 1053814C
Authority
CN
China
Prior art keywords
herba
radix
flos magnoliae
rhinitis
moschus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94101473A
Other languages
Chinese (zh)
Other versions
CN1099641A (en
Inventor
江洪彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94101473A priority Critical patent/CN1053814C/en
Publication of CN1099641A publication Critical patent/CN1099641A/en
Application granted granted Critical
Publication of CN1053814C publication Critical patent/CN1053814C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A liquid medicine for treating rhinitis and a preparation method thereof, the liquid medicine contains: fructus Xanthii, Moschus, Ginseng radix Rubri, spina Gleditsiae, mume fructus, radix astragali, flos Magnoliae, Saviae Miltiorrhizae radix, herba Ephedrae, herba Menthae, herba Centipedae, Mel, etc. When extracting effective components, flos Magnoliae and herba Menthae by distillation; extracting Ginseng radix Rubri, spina Gleditsiae, herba Ephedrae, herba Centipedae, Saviae Miltiorrhizae radix, radix astragali, fructus Xanthii, and mume fructus; moschus and Mel can be directly dissolved in the medicinal liquid. The medicine has the characteristics of convenient use, quick curative effect, safety, reliability and no side effect, the total effective rate of the medicine for treating various acute and chronic rhinitis reaches 100 percent, and the cure rate is more than 95 percent.

Description

Medicinal liquid of treatment rhinitis and preparation method thereof
The present invention relates to treat the Chinese medicine preparation and the method for making thereof of rhinitis, particularly relate to a kind of medicinal liquid and method for making thereof that acute rhinitis and obstinate chronic rhinitis is all had the treatment rhinitis of good efficacy.
Present commercially available rhinitis medicine has a variety of, but curative effect is all undesirable.BIYANKANG for example, it has certain curative effect to rhinitis, but cures the symptoms, not the disease, and particularly chronic rhinitis is difficult to reach the effect of radical cure.In addition, in " Chinese patent medicine research " (6): put down in writing the Chinese medicine preparation one rhinitis record of a kind for the treatment of acute and chronic sinusitis, rhinitis in 25 (1983), contain in the said preparation: 9 kinds of Chinese medicines such as Fructus Xanthii, Flos Magnoliae, Flos Chrysanthemi Indici, the Radix Angelicae Dahuricae, Herba Asari, Herba Centipedae, Herba Menthae, Ramulus Mori, Radix Glycyrrhizae, though said preparation has certain curative effect to general rhinitis, yet it is relatively poor to the effect of intractable rhinitis, and also not ideal enough to the effect of allergic rhinitis.
The objective of the invention is to overcome the shortcoming of existing rhinitis medicine, provide a kind of can anti-inflammation hemostasia, blood circulation promoting and blood stasis dispelling, have one's ideas straightened out only tears, antiallergic, raising immunity, to acute or chronic rhinitis, particularly to specific Chinese medicine preparation of intractable rhinitis and preparation method that said preparation is provided.
The inventor combines the characteristics of multiple prescription, and according to " the pharmacological property of the various medicines of first record of Chinese pharmacopoeia nineteen ninety version, carried out the research of various combination formulas, repetition test through the several years, finally found and a kind ofly both acute rhinitis had been taken effect rapidly, can effect a radical cure the intractable rhinitis again simultaneously, and safe in utilization, the medicinal liquid of treatment rhinitis without any side effects has so far been finished the present invention.
The medicinal liquid of treatment rhinitis of the present invention contains: Chinese medicine ingredients such as Fructus Xanthii, Moschus, Radix Ginseng Rubra, Spina Gleditsiae, Fructus Mume, the Radix Astragali, Flos Magnoliae, Radix Salviae Miltiorrhizae, Herba Ephedrae, Herba Menthae, Herba Centipedae, Mel.
When the medicinal liquid of preparation treatment rhinitis of the present invention, the weight portion proportioning of used above-mentioned various medicines is: Fructus Xanthii 125-500, Moschus 0.012-0.5, Radix Ginseng Rubra 25-100, Spina Gleditsiae 12.5-50, Fructus Mume 12.5-50, Radix Astragali 62.5-250, Flos Magnoliae 2.5-250, Radix Salviae Miltiorrhizae 62.5-250, Herba Ephedrae 6.25-50, Herba Menthae 35-150, Herba Centipedae 62.5-250, Mel 1.25-5.
The preparation method of the medicinal liquid of treatment rhinitis of the present invention is as follows: by said ratio, get Flos Magnoliae, Spina Gleditsiae, Herba Ephedrae, Herba Menthae, the Radix Astragali, Herba Centipedae, Radix Salviae Miltiorrhizae and break into coarse powder respectively, the Radix Ginseng Rubra section, get Flos Magnoliae, Herba Menthae two flavors then and place distillator, be equivalent to this two flavors medicine gross weight 8-12 water doubly toward wherein adding,, get the collection distillate 100 ℃ of distillations down, do not have to the distillator till the residue liquid phase, preserve medicinal residues and distillate standby respectively; In addition, get Radix Ginseng Rubra, Spina Gleditsiae, Herba Ephedrae, Herba Centipedae, Radix Salviae Miltiorrhizae, the Radix Astragali, Fructus Xanthii, Fructus Mume eight flavor crude drug in whole and Flos Magnoliae, medicinal residues fusion after the Herba Menthae two flavor distillations, add water and be heated to 100 ℃ and leach twice of extraction, wherein, for the first time adding water 7-9 doubly measures (by crude drug weight, down together), heated 1.5-2.5 hour, for the second time adding water 5-7 doubly measures, heated 0.5-1.5 hour, filter, twice filtrate is merged, Moschus is dissolved with this filtrate, then with this Moschus aqueous solution and above-mentioned distillation distillate merging, add the Mel mixing after cooling, the reuse distilled water is adjusted to the contained effective ingredient of every 1ml medicinal liquid and is equivalent to crude drug in whole 2-4g, adds the antiseptic mud pool gold of total liquid measure 0.3% (weight) at last.Last fill finished product.
The using method of the medicinal liquid of treatment rhinitis of the present invention is as follows: a small amount of medical absorbent cotton is made cotton balls, libation at an ancient wedding ceremony taking liquid 2-3ml, vertically the about 2cm of insertion is dark in a nostril, kept about 15 minutes, after taking out this cotton balls, handle another nostril more in the same way, like this every day 1-2 time, per 10 days is a course of treatment.The careful usefulness of anemia of pregnant woman.
The effect of the medicinal liquid of treatment rhinitis of the present invention is as follows: Pharmacy department of Yulin Prefecture People's Hospital carries out chronic, acute toxicity test by Guangxi, and result of the test shows, and is safe in utilization, has no side effect, easy to use, and curative effect is (seeing Appendix) rapidly.By 40,000 routine clinical treatments, total effective rate reaches 100%, and cure rate is more than 95%, the radical rate height.
Embodiment
The prescription that adopts is (weight portion): Fructus Xanthii 450, Moschus 0.45, Radix Ginseng Rubra 80, Spina Gleditsiae 45, Fructus Mume 45, the Radix Astragali 220, Flos Magnoliae 220, Radix Salviae Miltiorrhizae 220, Herba Ephedrae 45, Herba Menthae 130, Herba Centipedae 220, Mel 4.Weigh up various medicines by said ratio, get Flos Magnoliae, Spina Gleditsiae, Herba Ephedrae, Herba Menthae, the Radix Astragali, Herba Centipedae, Radix Salviae Miltiorrhizae and break into coarse powder respectively, the Radix Ginseng Rubra section, get Flos Magnoliae, Herba Menthae two flavors then and place distillator, toward wherein adding the water that is equivalent to 10 times of this two flavors medicine gross weights,, collect distillate 100 ℃ of distillations down, to distillator, do not have the residue liquid phase, preserve medicinal residues and distillate standby respectively; In addition, get Radix Ginseng Rubra, Spina Gleditsiae, Herba Ephedrae, Herba Centipedae, Radix Salviae Miltiorrhizae, the Radix Astragali, Fructus Xanthii, Fructus Mume eight flavor crude drug in whole and Flos Magnoliae, medicinal residues fusion after the Herba Menthae two flavor distillations, add water and be heated to 100 ℃ and leach twice of extraction, wherein, for the first time add 8 times of amounts of water (by crude drug weight, down together), heated 2 hours, add for the second time 6 times of amounts of water, heated 1 hour, and filtered, twice filtrate is merged, the filtrate that takes a morsel is dissolved whole Moschus, then it is mixed with remaining filtrate, with this Moschus aqueous solution and above-mentioned distillation distillate merging, add the Mel mixing after cooling again, the reuse distilled water is adjusted to the contained effective ingredient of every 1ml medicinal liquid and is equivalent to crude drug in whole 3g, adds the antiseptic mud pool gold of total liquid measure 0.3% (weight) at last.The amount finished product is the water preparation of black, last filling and package finished product.

Claims (3)

1 one kinds of medicinal liquids that are used for the treatment of rhinitis is characterized in that, it is made by following weight portion by following traditional Chinese medicines:
Fructus Xanthii 120-500, Moschus 0.012 0.5, Radix Ginseng Rubra 25-100, Spina Gleditsiae 12.5-50, Fructus Mume 12.5-50, Radix Astragali 62.5-250, Flos Magnoliae 62.5-250, Radix Salviae Miltiorrhizae 62.5-250, Herba Ephedrae 62.5-50, Herba Menthae 35-150, Herba Centipedae 62.5-250, Mel 1.25-5.
According to the medicinal liquid of the described treatment rhinitis of claim 1, it is characterized in that 2, it is made by following weight portion by following traditional Chinese medicines:
Fructus Xanthii 450, Moschus 0.45, Radix Ginseng Rubra 80, Spina Gleditsiae 45, Fructus Mume 45, the Radix Astragali 220, Flos Magnoliae 220, Radix Salviae Miltiorrhizae 220, Herba Ephedrae 45, Herba Menthae 130, Herba Centipedae 220, Mel 4.
3, the preparation method of the medicinal liquid of the described treatment rhinitis of claim 1, it is characterized in that, take by weighing various medicines according to the described proportioning of claim 1, wherein Flos Magnoliae, Spina Gleditsiae, Herba Ephedrae, Herba Menthae, the Radix Astragali, Herba Centipedae, Radix Salviae Miltiorrhizae are broken into coarse powder respectively, Radix Ginseng Rubra section is got Flos Magnoliae, Herba Menthae two flavors place distillator, collect the gold-plating fluid then, do not have to the distillator till the residue liquid phase, preserve medicinal residues and gold-plating fluid standby respectively; In addition, get Radix Ginseng Rubra, Spina Gleditsiae, Herba Ephedrae, Herba Centipedae, Radix Salviae Miltiorrhizae, the Radix Astragali, Fructus Xanthii, Fructus Mume eight flavor crude drug in whole and Flos Magnoliae, medicinal residues fusion after the Herba Menthae two flavor distillations, add water and be heated to 100 ℃ and leach twice of extraction, wherein, for the first time adding water 7-9 doubly measures (by crude drug weight, down together) heating is 1.5-2.5 hour, for the second time adding water 5-7 doubly measures, heated 0.5-1.5 hour, filter, twice filtrate is merged, with this filtrate Moschus is dissolved, with this perfume solution and above-mentioned distillation gold-plating fluid merging, add the Mel mixing after cooling then, the reuse distilled water is adjusted to the contained effective ingredient of every 1ml medicinal liquid and is equivalent to crude drug in whole 2-4, adds the antiseptic mud pool gold of total liquid measure 0.3% (weight) at last.
CN94101473A 1994-03-02 1994-03-02 Medicinal liquid for treating rhinitis and preparation method thereof Expired - Fee Related CN1053814C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94101473A CN1053814C (en) 1994-03-02 1994-03-02 Medicinal liquid for treating rhinitis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94101473A CN1053814C (en) 1994-03-02 1994-03-02 Medicinal liquid for treating rhinitis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN1099641A CN1099641A (en) 1995-03-08
CN1053814C true CN1053814C (en) 2000-06-28

Family

ID=5030183

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94101473A Expired - Fee Related CN1053814C (en) 1994-03-02 1994-03-02 Medicinal liquid for treating rhinitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1053814C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058415C (en) * 1996-03-18 2000-11-15 杜威 Method for preparing liquid medicine guiding agent and liquid medicine guiding agent prepared by the method
CN101007123B (en) * 2006-01-25 2011-08-10 苏德 Medicinal composition for treating and relieving rhinitis
CN101554403B (en) * 2009-05-26 2011-06-01 曹书光 Medicament for treating rhinitis and preparation method thereof
CN102908607B (en) * 2012-11-20 2014-05-07 青岛华仁技术孵化器有限公司 External traditional Chinese medicine for treating chronic simple rhinitis and preparation method thereof
CN105687557A (en) * 2016-01-26 2016-06-22 刘汉业 Herbal rhinitis ointment and production method of herbal rhinitis ointment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073865A (en) * 1991-12-29 1993-07-07 王锐 The manufacture method of allergic rhinitis extract
CN1078636A (en) * 1992-05-12 1993-11-24 范占强 A kind of pharmaceutical composition for the treatment of rhinitis and preparation method thereof
CN1079150A (en) * 1992-05-28 1993-12-08 杨展 Method for preparing Chinese medicine injection for treating rhinitis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073865A (en) * 1991-12-29 1993-07-07 王锐 The manufacture method of allergic rhinitis extract
CN1078636A (en) * 1992-05-12 1993-11-24 范占强 A kind of pharmaceutical composition for the treatment of rhinitis and preparation method thereof
CN1079150A (en) * 1992-05-28 1993-12-08 杨展 Method for preparing Chinese medicine injection for treating rhinitis

Also Published As

Publication number Publication date
CN1099641A (en) 1995-03-08

Similar Documents

Publication Publication Date Title
CN100434114C (en) Heath caring pillow of ganoderma lucidum
CN100394951C (en) Medicine for treating insomnia and preparation method thereof
CN1053814C (en) Medicinal liquid for treating rhinitis and preparation method thereof
CN1233251C (en) Tea capable of preventing and curing hypertension
CN106038479B (en) A kind of frutus cnidii micro-capsule thermo-sensitive gel and preparation method thereof and quality determining method
CN101912596B (en) Medicament for treating allergic rhinitis and preparation method thereof
CN101417033B (en) Traditional Chinese medicine for treating insomnia
CN1115654A (en) Kidney-reinforcing oral medicine and its prepn
CN101810843B (en) Medicament for treating nerve system diseases such as cerebrovascular accident, spinal cord injury and senile dementia
CN101987156B (en) Medicine for treating toothache and preparation method thereof
CN101450189B (en) Medicine for curing angiocardiopathy and cerebrovascular disease and its preparing method
CN103656239B (en) A kind of Chinese drugs agentia for the treatment of wind syndrome of head and preparation method thereof
CN101401885B (en) Liquid medicine for removing miliaria and preparation method thereof
CN101229224B (en) Chinese traditional medicine ointment preparation for curing vitligo and preparing method thereof
CN104888124A (en) Synthetic process and detection method for mianserin hydrochloride
CN1132093A (en) Antidiarrheal liquid for treatment of cold diarrhea
CN1069058C (en) Compound medicament for treating chronic pelvic inflammation
CN103736011B (en) Injection care drug of a kind of cholesterol reducing and preparation method thereof
CN1129442C (en) Cold-preventing and spleen-invigorating paste
CN1059829C (en) Nourishing heart and rising heart rhythm drink and preparation method
CN1251669C (en) Acne removing and skin rejuvenating cream
CN1097341A (en) Naomaitong hat lining
CN102370838B (en) Kidney-invigorating and tendon-reinforcing double-phase capsule
CN105125904A (en) Pharmaceutical composition for treating cerebral hemorrhage
CN101912547B (en) Medicament for treating dizziness and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee